Keywords
Cyclin D1
Carcinoma, squamous cell
How to Cite
Abstract
Oral squamous cell carcinoma (OSCC) is one of the most well-known malignancies that affect the human population worldwide. The early diagnosis and early intervention of OSCC help improve the survival rate of the patients. The tumour free surgical margins are a positive prognostic factor for recurrence-free survival. The molecular markers can be used to detect the tumour free surgical margins. Aim: The aim of the study is to evaluate the expression of p53 & Cyclin D1 marker in resected surgical apparently clear margins and to correlate the p53 & Cyclin D1 expression with clinicopathological characteristics and patient outcome. Methods: The study population included retrospective cases of OSCC with apparently clear margins (2017-18) n=10 and Clinicopathological variables relevant to survival analysis were recorded. Finally, two margins were selected from each case, a total of 20 margins were included in this study. Paraffin-embedded wax blocks retrieved and tissue sections were made. Expression of cyclin D1 and p 53 was assessed by the immunohistochemical staining procedure Results: Positive expressions Cyclin D1 in 40% of mild dysplasia margins and 60% in clearance adequate margins were present. p53 expression was seen in 16% of mild dysplasia margins and 84% in clearance adequate margins. The expression of p53 and Cyclin D1 molecular markers are noted in the basal & parabasal layer of epithelium. Conclusion: Molecular markers could play a more reliable method for the assessment of dysplasia at the margins.
References
Ghafari R, Jalayer Naderi N, Emami Razavi A. A retrospective institutional study of histopathologic pattern of Oral Squamous Cell Carcinoma (OSCC) in Tehran, Iran during 2006-2015. J Res Med Sci. 2019 Jun;24:53. doi: 10.4103/jrms.JRMS_882_18.
Coelho KR. Challenges of the oral cancer burden in India. J Cancer Epidemiol. 2012;2012:701932. doi: 10.1155/2012/701932.
Kamat M, Rai BD, Puranik RS, Datar UV. A comprehensive review of surgical margin in oral squamous cell carcinoma highlighting the significance of tumor-free surgical margins. J Cancer Res Ther. 2019 Jul-Sep;15(3):449-54. doi: 10.4103/jcrt.JCRT_273_17.
Yang XH, Ding L, Fu Y, Chen S, Zhang L, Zhang XX, et al. p53-positive expression in dysplastic surgical margins is a predictor of tumor recurrence in patients with early oral squamous cell carcinoma. Cancer Manag Res. 2019 Feb;11:1465-72. doi: 10.2147/CMAR.S192500.
Sakashita T, Homma A, Suzuki S, Hatakeyama H, Kano S, Mizumachi T, et al. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas. Acta Otolaryngol. 2013 Sep;133(9):984-91. doi: 10.3109/00016489.2013.795287.
Bilde A, von Buchwald C, Dabelsteen E, Therkildsen MH, Dabelsteen S. Molecular markers in the surgical margin of oral carcinomas. J Oral Pathol Med. 2009 Jan;38(1):72-8. doi: 10.1111/j.1600-0714.2008.00715.x.
Sheriff K, Santhanam A. Knowledge and awareness towards oral biopsy among students of Saveetha Dental College. Res J Pharm Technol. 2018;11(2):543-6. doi: 10.5958/0974-360X.2018.00101.4.
Zhong LP, Zhu DW, William WN Jr, Liu Y, Ma J, Yang CZ, et al. Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease. Mol Cancer Ther. 2013 Jun;12(6):1112-21. doi: 10.1158/1535-7163.MCT-12-1013.
Duraiyan J, Govindarajan R, Kaliyappan K, Palanisamy M. Applications of immunohistochemistry. J Pharm Bioallied Sci. 2012 Aug;4(Suppl 2):S307-9. doi: 10.4103/0975-7406.100281.
Hornick JL. Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors. Mod Pathol. 2014 Jan;27 Suppl 1:S47-63. doi: 10.1038/modpathol.2013.177.
Singh J, Jayaraj R, Baxi S, Mileva M, Skinner J, Dhand NK, et al. Immunohistochemical expression levels of p53 and eIF4E markers in histologically negative surgical margins, and their association with the clinical outcome of patients with head and neck squamous cell carcinoma. Mol Clin Oncol. 2016 Feb;4(2):166-72. doi: 10.3892/mco.2015.689.
Sawair F, Hassona Y, Irwin C, Stephenson M, Hamilton P, Maxwell P, et al. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence. Asian Pac J Cancer Prev. 2016;17(3):1243-9. doi: 10.7314/apjcp.2016.17.3.1243.
Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology. 2004 Dec;145(12):5439-47. doi: 10.1210/en.2004-0959.
Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol. 1995 May;15(5):2600-11. doi: 10.1128/mcb.15.5.2600.
Shehenaz A, Santhanam A, Jayaraj G, Ramani P. Correlation of levels of lymph node, node involvement, gender predilection and histopathology in surgical pathology specimen of oral squamous cell carcinoma. Int J Res Trends Innov. 2017;2(8):149-53.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Brazilian Journal of Oral Sciences
Downloads
